Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin

Figure 1

CMV PCR trend following initiation of therapy. Patients 1 and 4 developed recurrent viremia following discontinuation of therapy. Viral load became undetectable quickly in Patient 1 after resumption of therapy and after several dosages in Patient 4.